Research / ORCL / Fundamental state Inspectable configuration
State dimensions Filing 0001193125-17-372232 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.23% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
6.49% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
4.53% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
60.47% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
31.90% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
15.33% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
4.34% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 40 states Self-history eligible
Nov 30, 2021 6/6 normalized Level 3 Feb 28, 2022 6/6 normalized Level 3 May 31, 2022 7/8 normalized Level 3 Aug 31, 2022 6/6 normalized Level 3 Nov 30, 2022 6/6 normalized Level 3 Feb 28, 2023 6/6 normalized Level 3 May 31, 2023 7/7 normalized Level 3 Aug 31, 2023 6/6 normalized Level 3 Nov 30, 2023 6/6 normalized Level 3 Feb 29, 2024 6/6 normalized Level 3 May 31, 2024 7/7 normalized Level 3 Aug 31, 2024 6/6 normalized Level 3 Nov 30, 2024 6/6 normalized Level 3 Feb 28, 2025 6/6 normalized Level 3 May 31, 2025 7/7 normalized Level 3 Aug 31, 2025 6/6 normalized Level 3 Nov 30, 2025 6/6 normalized Level 3 Feb 28, 2026 6/6 normalized Level 3 May 31, 2026 6/6 normalized Level 3 Aug 31, 2026 6/6 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 5.15%
Current 6.23%
Delta 1.08% Growth Decreased
Previous 6.89%
Current 6.49%
Delta -0.40% Inventory Pressure Increased
Previous 3.40%
Current 4.53%
Delta 1.14% Margin Increased
Previous 59.94%
Current 60.47%
Delta 0.53% Profitability Increased
Previous 30.71%
Current 31.90%
Delta 1.19% R And D Intensity Decreased
Previous 17.13%
Current 15.33%
Delta -1.80% Sbc Intensity Decreased
Previous 4.39%
Current 4.34%
Delta -0.04% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.